These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 16291600)

  • 41. The gastrointestinal safety and effect on disease activity of etoricoxib, a selective cox-2 inhibitor in inflammatory bowel diseases.
    El Miedany Y; Youssef S; Ahmed I; El Gaafary M
    Am J Gastroenterol; 2006 Feb; 101(2):311-7. PubMed ID: 16454836
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rofecoxib 50 mg and valdecoxib 20 or 40 mg in adults and adolescents with postoperative pain after third molar extraction: results of two randomized, double-blind, placebo-controlled, single-dose studies.
    Daniels SE; Desjardins PJ; Bird SR; Smugar SS; Tershakovec AM
    Clin Ther; 2006 Jul; 28(7):1022-34. PubMed ID: 16990080
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Peptic ulcer and bleeding events associated with rofecoxib in a 3-year colorectal adenoma chemoprevention trial.
    Lanas A; Baron JA; Sandler RS; Horgan K; Bolognese J; Oxenius B; Quan H; Watson D; Cook TJ; Schoen R; Burke C; Loftus S; Niv Y; Ridell R; Morton D; Bresalier R
    Gastroenterology; 2007 Feb; 132(2):490-7. PubMed ID: 17258718
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Etoricoxib versus indometacin in the treatment of Chinese patients with acute gouty arthritis: a randomized double-blind trial.
    Li T; Chen SL; Dai Q; Han XH; Li ZG; Wu DH; Zhang X; Gu JR; Yang NP; Sun LY; Zhang MJ; Li XF; Bao CD
    Chin Med J (Engl); 2013; 126(10):1867-71. PubMed ID: 23673101
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Etoricoxib reduced pain and disability and improved quality of life in patients with chronic low back pain: a 3 month, randomized, controlled trial.
    Pallay RM; Seger W; Adler JL; Ettlinger RE; Quaidoo EA; Lipetz R; O'Brien K; Mucciola L; Skalky CS; Petruschke RA; Bohidar NR; Geba GP
    Scand J Rheumatol; 2004; 33(4):257-66. PubMed ID: 15370723
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of etoricoxib for pain relief during endometrial biopsy; a double blind randomized controlled trial.
    Tanprasertkul C; Pongrojpow D
    J Med Assoc Thai; 2008 Jan; 91(1):13-8. PubMed ID: 18386538
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of multiday analgesia with etoricoxib in a double-blind, randomized controlled trial using the postoperative third-molar extraction dental pain model.
    Brown JD; Daniels SE; Bandy DP; Ko AT; Gammaitoni A; Mehta A; Boice JA; Losada MC; Peloso PM
    Clin J Pain; 2013 Jun; 29(6):492-8. PubMed ID: 23247002
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Comparison of preemptive analgesia efficacy between etoricoxib and rofecoxib in ambulatory gynecological surgery].
    Liu W; Loo CC; Tan HM; Ye TH; Ren HZ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Dec; 26(6):666-70. PubMed ID: 15663229
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of etoricoxib on the pharmacokinetics of oral contraceptives in healthy participants.
    Schwartz J; Hunt T; Smith WB; Wong P; Larson P; Crumley T; Mehta A; Gottesdiener K; Agrawal N
    J Clin Pharmacol; 2009 Jul; 49(7):807-15. PubMed ID: 19443681
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A case report on toxic epidermal necrolysis with etoricoxib.
    Kameshwari JS; Devde R
    Indian J Pharmacol; 2015; 47(2):221-3. PubMed ID: 25878388
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A comparison of rofecoxib versus celecoxib in treating pain after dental surgery: a single-center, randomized, double-blind, placebo- and active-comparator-controlled, parallel-group, single-dose study using the dental impaction pain model.
    Malmstrom K; Fricke JR; Kotey P; Kress B; Morrison B
    Clin Ther; 2002 Oct; 24(10):1549-60. PubMed ID: 12462285
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Single dose oral etoricoxib for acute postoperative pain in adults.
    Clarke R; Derry S; Moore RA; McQuay HJ
    Cochrane Database Syst Rev; 2009 Apr; (2):CD004309. PubMed ID: 19370600
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assessment of upper gastrointestinal safety of etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison.
    Laine L; Curtis SP; Cryer B; Kaur A; Cannon CP;
    Lancet; 2007 Feb; 369(9560):465-73. PubMed ID: 17292766
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dose proportionality of oral etoricoxib, a highly selective cyclooxygenase-2 inhibitor, in healthy volunteers.
    Agrawal NG; Porras AG; Matthews CZ; Woolf EJ; Miller JL; Mukhopadhyay S; Neu DC; Gottesdiener KM
    J Clin Pharmacol; 2001 Oct; 41(10):1106-10. PubMed ID: 11583479
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy and safety of rofecoxib in patients with chronic low back pain: results from two 4-week, randomized, placebo-controlled, parallel-group, double-blind trials.
    Katz N; Ju WD; Krupa DA; Sperling RS; Bozalis Rodgers D; Gertz BJ; Gimbel J; Coleman S; Fisher C; Nabizadeh S; Borenstein D;
    Spine (Phila Pa 1976); 2003 May; 28(9):851-8; discussion 859. PubMed ID: 12941996
    [TBL] [Abstract][Full Text] [Related]  

  • 56. No effect of the cyclooxygenase-2 inhibitor etoricoxib on pre-emptive and post-operative analgesia in visceral surgery: results of a randomized controlled trial.
    Fleckenstein J; Kohls N; Evtouchenko E; Lehmeyer L; Kramer S; Lang PM; Siebeck M; Mussack T; Hatz R; Heindl B; Conzen P; Rehm M; Czerner S; Zwißler B; Irnich D
    Eur J Pain; 2016 Feb; 20(2):186-95. PubMed ID: 25828692
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The safety profile, tolerability, and effective dose range of rofecoxib in the treatment of rheumatoid arthritis. Phase II Rofecoxib Rheumatoid Arthritis Study Group.
    Schnitzer TJ; Truitt K; Fleischmann R; Dalgin P; Block J; Zeng Q; Bolognese J; Seidenberg B; Ehrich EW
    Clin Ther; 1999 Oct; 21(10):1688-702. PubMed ID: 10566565
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The analgesic effect of etoricoxib relative to that of cetaminophen analgesics: a randomized, controlled single-dose study in acute dental impaction pain.
    Malmstrom K; Ang J; Fricke JR; Shingo S; Reicin A
    Curr Med Res Opin; 2005 Jan; 21(1):141-9. PubMed ID: 15881486
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Effect of nonsteroidal anti-inflammatory drugs on the indicators of cardiovascular risk in patients with acute nonspecific back pain].
    Zolotovskaya IA; Davydkin IL
    Ter Arkh; 2015; 87(12):18-25. PubMed ID: 26978413
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Management of acute Achilles tendinopathy: effect of etoricoxib on pain control and leg stiffness.
    Maquirriain J; Kokalj A
    Georgian Med News; 2013 Sep; (222):36-43. PubMed ID: 24099813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.